Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common / Ordinary Stock
-
Total 13F shares
-
5,107,341
-
Share change
-
+157,047
-
Total reported value
-
$703,276,473
-
Put/Call ratio
-
419%
-
Price per share
-
$142.89
-
Number of holders
-
119
-
Value change
-
+$22,087,208
-
Number of buys
-
70
-
Number of sells
-
49
Institutional Holders of Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) as of Q3 2015
As of 30 Sep 2015,
Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,107,341 shares.
The largest 10 holders included
ISZO CAPITAL MANAGEMENT LP, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, SCHRODER INVESTMENT MANAGEMENT GROUP, Greywolf Capital Management LP, Think Investments LP, Eqis Capital Management, Inc., BlueMountain Capital Management, LLC, and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC.
This page lists
119
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.